Mixed Q2 for Humana: Earnings Beat and Cost Control, but No Guidance Raise Sparks Selloff
Humana posts $7.61 adjusted EPS, topping estimates as costs remain in line; shares decline after full-year guidance is reaffirmed without an increase.
Humana posts $7.61 adjusted EPS, topping estimates as costs remain in line; shares decline after full-year guidance is reaffirmed without an increase.
Vertiv’s Q2 revenue of $3.27B missed $3.37B estimates due to supply delays, despite EPS beat and raised guidance.
Teradyne reports record $1.33B Q2 revenue, more than double last year, and beats estimates. Strong AI chip demand drives upbeat Q3 guidance.
Leveraged selling and SK Hynix’s earnings miss wiped $2 trillion from South Korean stocks in two days of record market declines.
AI-driven demand lifts KLA to $3.66B Q4 revenue and $1.05 EPS beat.
Weak volumes, smaller customer base and ongoing losses raise profitability doubts.